Coagulation Flashcards
Treatment of thromboembolism:
1.) Anticoagulant- Parenteral
2.) Anticoagulant- Oral
3.) Anti-platelets
4.) Thrombolytics (name 3 drugs)
Name drugs in each class and what we need to know them
Oh no you’re bleeding! Who’s more at risk?
Name some anti-fibrinolytic or hemostatic drugs
Higher risk for elderly women/ pt w renal failure - heparin bleed
Aminocaproic Acid
Tranexamic Acid (TXA)
Vitamin K, Plasma fractions
(Factor replenishers)
Plasminogen to Plasmin Pathway
Rivaroxaban
Factor 10 inhibitor
Anti-coagulant- clot prevention for DVT
Apixaban
Factor 10 Inhibitor
Anti-coagulant- clot prevention for DVT
Warfarin :)
Direct thrombin Inhibitor, target thrombin and DVT
Blocks vitamin K reductase and blocks carboxylation of glutamate residues. Reduce factor
OD/Bleed? Vitamin K, Replenish factors 2, 7, 9, 10, FFP
TOXIC:
-Birth defects, hemorrhagic disorder in fetus, cutaneous necrosis
Indirect Thrombin Inhibitors
What do they target, MOA?
Drugs?
-Unfractionated Heparin (^risk HITT)
-LMW Heparin
Dalteparin (Fragmin)
LMW Heparin (Target venous thrombus)
More specific for factor 10
Indirect Thrombin Inhibitor
Enoxaparin (Lovenox)
LMW Heparin (Target venous thrombus)
More specific for factor 10
Indirect Thrombin Inhibitor
Tinzaparin (Innohep)
LMW Heparin (Target venous thrombus)
More specific for factor 10
Indirect Thrombin Inhibitor
Fondaparinux (Arixtra)
Heparin
But not selective for Factor 10, no antibody response
What do these check for? Normal values?
INR
PT
aPTT
INR: Time it takes to clot compared to control (Warfarin goal 2-3, normal 0.8-1.2)
PT: Time to clot. (checking extrinsic pathway so factor 7,10, thrombin)
aPTT: activated partial thromboplastin time (checking intrinsic pathway)
Protamine Sulfate
Reversal for heparin
Argatroban
(Not on study guide)
Direct Thrombin Inhibitor
*Active thrombin Site
Melagatran
Direct Thrombin Inhibitor
*Active thrombin Site
Dabigatran (Pradaxa)
Direct Thrombin Inhibitor
*Active thrombin Site
Hirudin (Lepriudin)**
Direct Thrombin Inhibitor
*Bind to both active & substrate recognition sites of thrombin